John Stone
🏛️ Revolving DoorFormer Government Positions:
Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel,House E&C Ctme Health Subcommittee
See prior filing
Counsel, House E&C Cmte, Oversight Subcmte; Senior Counsel,House E&C Cmte Health Subcmte
🤖
AI Overview
John Stone has appeared in 950 federal lobbying filings at BGR Government Affairs, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 13 policy areas.
950
Total Filings
1
Firms
50
Clients
13
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 89 | 28 |
| 2019 | 140 | 38 |
| 2020 | 111 | 36 |
| 2021 | 115 | 36 |
| 2022 | 111 | 30 |
| 2023 | 114 | 28 |
| 2024 | 105 | 31 |
| 2025 | 165 | 40 |
Firms
BGR Government Affairs950 filings
Top Clients
Advanced Medical Technology Association32 filings
Glaxosmithkline, INC32 filings
Biotechnology Innovation Organization31 filings
Abiomed INC30 filings
Rai Services Company30 filings
Neurocrine Biosciences, INC.29 filings
Walgreen Co.28 filings
Senior Care Pharmacy Coalition27 filings
Amgen INC.27 filings
Edwards Lifesciences LLC25 filings
Ptc Therapeutics25 filings
Charles River Laboratories24 filings
Novartis23 filings
Bayer Corporation22 filings
Recess21 filings
Horizon Pharma19 filings
Stryker Corporation18 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.